The pharmaceutical industry and its allies — which once included most elected Republicans — have met President-elect Trump's nomination of one of America's leading vaccine skeptics to lead the country's premier health agency with surprisingly muted response.
Why it matters: Trump's domination of the Republican party and the pharmaceutical industry's public acquiescence have made a Health and Human Services Secretary Robert F. Kennedy Jr. not only possible, but likely.